FAA Examines Fitness-For-Duty Rules as Federal Marijuana Policy Evolves

FAA Confirms Policy Review Underway

The FAA confirmed it's opened an internal review of its drug and alcohol testing program in response to the DEA's pending rescheduling of marijuana from Schedule I to Schedule III. The agency's current regulations, codified in 14 C.F.R. Part 120, prohibit safety-sensitive aviation employees from using marijuana regardless of state law. The review doesn't signal an immediate policy change, according to the statement.

The FAA's drug-testing program covers approximately 500,000 pilots, mechanics, flight attendants, and air traffic controllers. All employees in safety-sensitive roles are subject to random testing. They must maintain zero-tolerance compliance with federal controlled-substance prohibitions.

The agency didn't provide a timeline for completing the review or issuing updated guidance.

Rescheduling Proceeding Creates Regulatory Uncertainty

The DEA's proposed rescheduling of marijuana to Schedule III under the Controlled Substances Act wouldn't automatically legalize cannabis use by federal employees or contractors. Schedule III substances—including anabolic steroids and ketamine—remain controlled and subject to workplace restrictions in safety-sensitive industries. The DEA's administrative law judge hearing on the rescheduling proposal is scheduled to resume in late August 2026.

Federal agencies including the Department of Transportation, which oversees the FAA, have historically maintained zero-tolerance drug policies even for substances with accepted medical uses. The FAA's current Medical Certification policy explicitly disqualifies pilots who use marijuana, regardless of whether a state-issued medical card is present.

Industry groups including the National Air Traffic Controllers Association haven't yet issued public comments on the FAA's review.

Implications for Aviation Workforce and Enforcement

The FAA's review comes as aviation employers face mounting questions about off-duty cannabis use in states where recreational marijuana is legal. Twenty-four states and the District of Columbia have legalized adult-use cannabis. This creates a patchwork of state laws that conflict with federal aviation regulations. Pilots and mechanics who test positive for THC metabolites face certificate suspension or revocation, even if use occurred off-duty in a legal state.

Over the past three years, the agency has issued approximately 1,200 enforcement actions annually related to drug and alcohol violations, according to FAA enforcement data. Most involve failed random tests or post-accident screenings. The FAA didn't specify whether the review would address detection thresholds, lookback periods, or the use of non-psychoactive cannabinoids such as CBD.

What Happens Next

The FAA's review is procedural and doesn't indicate imminent regulatory changes. Any substantive revision to 14 C.F.R. Part 120 would require notice-and-comment rulemaking under the Administrative Procedure Act, a process that typically spans 18 to 36 months. Current drug-testing requirements remain in full effect during the review period.

For operators and employees, the practical takeaway is unchanged: marijuana use remains prohibited for anyone holding an FAA medical certificate or working in a safety-sensitive aviation role. For background on federal workplace drug policy and cannabis rescheduling, see the CannIntel topic hub on Federal Workplace Drug Testing and Cannabis Policy.

The next milestone: the DEA's administrative law judge hearing resumes August 25, 2026, with final testimony on the Schedule III proposal expected by September.